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Chloride transporter KCC2-dependent neuroprotection
depends on the N-terminal protein domain
A Winkelmann1,3, M Semtner*,1,3 and JC Meier*,1,2
Neurodegeneration is a serious issue of neurodegenerative diseases including epilepsy. Downregulation of the chloride
transporter KCC2 in the epileptic tissue may not only affect regulation of the polarity of GABAergic synaptic transmission but also
neuronal survival. Here, we addressed the mechanisms of KCC2-dependent neuroprotection by assessing truncated and mutated
KCC2 variants in different neurotoxicity models. The results identify a threonine- and tyrosine-phosphorylation-resistant KCC2
variant with increased chloride transport activity, but they also identify the KCC2 N-terminal domain (NTD) as the relevant minimal
KCC2 protein domain that is sufficient for neuroprotection. As ectopic expression of the KCC2-NTD works independently of full-
length KCC2-dependent regulation of Cl− transport or structural KCC2 C-terminus-dependent regulation of synaptogenesis, our
study may pave the way for a selective neuroprotective therapeutic strategy that will be applicable to a wide range of
neurodegenerative diseases.
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Neurodegeneration restricts neuron numbers during develop-
ment but can become a serious issue in disease conditions
such as temporal lobe epilepsy (TLE).1 GABA-activated Cl−
channels contribute to activity-dependent refinement of neural
networks by triggering the so-called giant depolarizing
potentials providing developing neurons with a sense of
activity essential for neuronal survival and co-regulation of
excitatory glutamatergic and (inhibitory) GABAergic synapses.2
By regulating transmembrane Cl− gradients KCC2 plays a vital
role in development and disease.3 In addition, KCC2 plays a
protein structural role in spine formation through its C-terminal
protein domain (CTD).4,5 Hence, regulation of KCC2 expression
and function is relevant for development and disease-specific
plasticity of neural networks.6–9
GlyR α3K RNA editing leads to proline-to-leucine substitu-
tion (P185L) in the ligand-binding domain and generates gain-
of-function neurotransmitter receptors.10–13 GlyR RNA editing
is upregulated in the hippocampus of patients with TLE and
leads to GlyR α3K185L-dependent tonic inhibition of neuronal
excitability associated with neurodegeneration.14 KCC2
expression promotes neuroprotection14,15 but whether this
involves regulation of transmembrane Cl− gradient or protein
structural role is a matter of debate.14,15
Here, we assessed neuroprotection through several
KCC2 variants in two different models of neurodegeneration
including chronic neuronal silencing (α3K185L model) and
acute neuronal overexcitation (NMDAmodel).14,15 The results
identify a threonine- and tyrosine-phosphorylation-resistant
KCC2 variant with increased Cl− transport activity, but they
also demonstrate that the N-terminal KCC2 protein domain
(NTD) is sufficient for neuroprotection.
Results
We first investigated the mechanisms underlying the neuro-
toxic effects of the RNA-edited GlyR α3K variant (α3K185L) on
primary hippocampal neurons as described.14 Neurons were
transfected at day in vitro (DIV) 6 either with non-edited (185P;
control) or RNA-edited GlyR α3K (185L) and maintained for
3 days in 10 μMglycine, a concentration that should selectively
activate GlyR α3K185L.10 As shown previously,14 ~ 50% of the
GlyR α3K185L-expressing neurons exhibited fragmented den-
drites and pyknotic nuclei (Figures 1a and c; Supplementary
Table 1), both clear indicators of neurodegeneration, whereas
overexpression of non-edited GlyR α3K185P in 10 μM glycine
had little effect on neuronal survival (Figures 1b and c).
Appearance of fragmented dendrites was not due to rapid
internalization of surface-labeled GlyR α3K185L because
comparable fluorescent signals were obtained upon cell
permeabilization (not shown). To further investigate the
possibility that GlyR activation is responsible for neurodegen-
eration, GlyR α3K185P-expressing neurons were maintained
under GlyR-activating conditions (400 μM glycine), and GlyR
α3K185L-expressing neurons under non-activating (0 μM
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glycine) conditions.10 In agreement with different apparent
glycine affinities of non-edited GlyR α3K185P and edited GlyR
α3K185L10 the data in Figure 1c clearly show that glycine-
dependent activation of GlyR α3K triggers neurodegeneration.
Expression of KCC2 is inversely correlated to GlyR RNA-
editing in TLE hippocampi.14 Two KCC2 RNA splice variants
with different N-termini are known16 (Supplementary Figure
1A), but neuroprotective effectswere demonstrated for KCC2b
only.14,15 We therefore tested whether KCC2a and KCC2b
protect neurons against GlyR α3K185L-mediated degeneration
(Figure 1c). KCC2a- and KCC2b-positive neurons were
identified with 2A self-processing peptide-coupled EGFP
(Supplementary Figure 1B). Co-expression of KCC2a and
KCC2b rescued the survival of neurons cultured under GlyR
α3K185L-activating conditions (Figure 1c; Supplementary
Table 1). This result confirms our previous data14 and
furthermore reveals that KCC2-dependent neuroprotection
does not depend on alternative splicing of exon 1.16 KCC2b
was henceforth used and referred to as ‘KCC2wt’.
Role of spontaneous neural network activity for GlyR-
dependent neurodegeneration. Spontaneous neuronal
activity at the beginning of experimental GlyR α3K185L
expression period is mainly dependent on GABAAR activa-
tion (Supplementary Figure 2), suggesting that inability of
chronically silent neurons with enduring GlyR α3K185L
activation14 to participate in spontaneous neural network
activity underlies neurodegeneration. To address this
possibility, we blocked either synaptic or synaptic and non-
synaptic GABAARs, as described,
17 using 0.2 μM or 3 μM of
the competitive GABAAR antagonist GABAzine. However,
neither 0.2 μM nor 3 μM GABAzine rescued chronically silent
neurons, and KCC2wt-dependent neuroprotection did not
require GABAAR activation (Figure 2a; Supplementary
Table 1). Furthermore, neurodegeneration/neuroprotection
did not require action-potential-dependent synaptic trans-
mission because tetrodotoxin (TTX) had no effect on
survival (Figure 2b; Supplementary Table 1). These results
suggest that intrinsic cellular mechanisms are responsible
for neurodegeneration rather than inability of chronically
silent neurons to participate in spontaneous neural network
activity.
Role of intracellular Ca2+ concentration for GlyR-
dependent neurodegeneration. Activation of non-
synaptic NMDA receptors (NMDARs) and Ca2+-activated
Cl− channel Clca1 were implicated in neurodegeneration,18
and changes in resting intracellular Ca2+ concentration
([Ca2+]i) are involved in excitotoxicity.
19 Thus, GlyR
α3K185L-dependent neuronal intrinsic mechanisms of neu-
rodegeneration may involve changes in intracellular Ca2+
homeostasis. To investigate this possibility, [Ca2+]i of
neurons expressing GlyR α3K185L or GlyR α3K185P in
10 μM glycine (i.e., receptor-activating and non-activating
conditions) were determined using fura-2, as described by
Jung et al.20 (Figure 3a). However, [Ca2+]i was comparable
Figure 1 GlyR activation-dependent neurodegeneration and KCC2-dependent neuroprotection. Images of neurons with surface-stained GlyR α3K185L (a) and GlyR α3K185P
(b). According to fragmented dendrites and pyknotic nuclei, neurodegeneration is obvious in neurons with continuous GlyR activation (a). (c) Quantification of the fraction of
surviving neurons in each condition reveals that neurodegeneration occurs only under GlyR α3K-activating conditions and that co-expression of KCC2 (either splice variant
KCC2a or KCC2b) protects neurons with continuous GlyR α3K185L activation. Numbers in the bar graphs indicate the number of cultures analyzed. For KCC2 protein structure
see Supplementary Figure 1. For values, see Supplementary Table 1. ***Po0.001
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in all conditions as [Ca2+]i in neurons with activated GlyR
α3K185L (78.9± 19.2 nM, n= 13) were similar to those in
neurons with non-activated GlyR α3K185P (69.4±11.1 nM,
n=10; P=0.7125) or untransfected neurons (80.6±6.2 nM,
n=194, P=0.9280; Figure 3b). These results rule out
increased [Ca2+]i as a cause of GlyR α3K
185L activation-
dependent neurodegeneration.
Enduring GlyR α3K185L activation persistently changes
neuronal intrinsic membrane properties. We next inves-
tigated neuronal intrinsic membrane properties including
membrane resistance (RN) and the reversal potential of all
membrane conductances, henceforth termed ‘membrane
reversal potential’ (Vrev), a value of transmembrane voltage
at which ionic diffusive and electrical forces counterbalance
and no net transmembrane current is observed. We used
gramicidin-perforated patch clamp because under this con-
dition the intracellular milieu is not dependent on the
recording pipette solution but on ion channels open at a
given time of recording. We used voltage-clamp configuration
and voltage pulses (−5mV) starting from the holding potential
(−50mV) to determine RN. Voltage ramps (from −100 to
− 30mV, 0.5 mV/ms; 140ms total duration) were used to
determine Vrev as exactly as possible according to reversal of
current–voltage (IV) relationships. To determine Vrev of
GABAAR-dependent currents (EGABA) IV curves measured
in the presence and absence of GABA were subtracted. The
fluorescent dye lucifer yellow and high Cl− concentration in
the pipette solution allowed monitoring stability of the
perforated patch configuration (Supplementary Figure 3A).
Neurons with GlyR α3K185L expression were identified
according to co-expression of mCherry fluorescent protein
(Supplementary Figure 3A).
We first analyzed IV relationships in the absence of GABA,
that is, under basal conditions (Figure 4a, ‘IVbas’), in control
neurons (mCherry only) and in neurons with activated GlyR
Figure 2 Spontaneous neuronal network activity does not play a role in GlyR-
dependent neurodegeneration. Quantification of the effects of GABAzine (a) and TTX
(1 μM, b) on the survival of neurons with activated GlyR α3K185L. Two different
GABAzine concentrations (0.2 and 3 μM) were used to block synaptic or synaptic and
non-synaptic GABAAR activation. Numbers in the bar graphs indicate the number of
cultures analyzed. For values, see Supplementary Table 1. Statistical significance is
indicated with ***Po0.001
Figure 3 Continuous GlyR α3K185L activation does not affect resting [Ca2+]i. Intracellular Ca
2+ concentration at rest ([Ca2+]i) was determined according to the procedure
described by Jung et al.20 (a) Neurons were loaded 2–3 days after transfection with fura-2. Red and gray traces correspond to signals obtained from a GlyR α3K185L-positive
neuron (red) and non-transfected neurons (gray) in the neighborhood of the transfected neuron in the same viewfield. A solution with 50 mM KCl was applied to monitor the
viability of the cells according to their response with regard to fura-2 signals. Cells that did not respond to 50 mM KCl with changes in the F340/F380 ratio were not included in the
determination of resting [Ca2+]i. Resting [Ca
2+]i was determined within the 10 s (marked with a yellow bar) prior to the application of 50 mM KCl. To obtain minimal (0 mM) and
maximal (10 mM) Ca2+ signals for calibration, cells were permeabilized with either 10 μM ionomycin or 10 μM 4-bromo-antibiotic A23187. 2 mM Mn2+ were applied to quench the
signal at the end of each experiment and to obtain background fluorescence that was subtracted from all F340 and F380 values. (b) GlyR α3K185L expression and activation in the
presence of 10 μM glycine does not affect resting [Ca2+]i. Numbers in the bar graphs indicate the number of neurons analyzed
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α3K185L and determined Vrev. In neurons with enduring GlyR
α3K185L activation, Vrev was significantly more depolarized
than in control neurons (Figures 4a and c; −52.1±1.1 mV,
n= 12 versus −63.6± 2.7 mV, n=12; P= 0.0005). Further-
more, RN of neurons with enduring GlyR α3K
185L activation
was significantly decreased compared to control neurons
(Figure 4d; 108±31MΩ, n= 12 versus 429± 65MΩ, n= 12;
P=0.0012), indicating presence of open GlyR α3K185L
channels in the plasma membranes of neurons exposed to
10 μM glycine.
We next determined EGABA by subtracting IV curves
measured in the presence (IVGABA) and absence (IVbas) of
100 μMGABA (Figures 4a, b and e21). EGABA values should be
a measure of Vrev of Cl
− currents because GABAARs are like
GlyRs permeable for Cl−. GABAARs are also permeable for
HCO3
− (PHCO3/PCl∼ 0.5–0.622,23), but as our solutions were
not based on CO2/HCO3
−, the determined EGABA values
primarily reflect Vrev of Cl
−, that is ECl. Most of the control
neurons displayed hyperpolarizing currents at −50mV in
100 μM GABA (Figure 4a, left hand), which reversed at
−58.7± 2.3mV (n= 12; Figures 4b). In contrast, in neurons
with enduring GlyR α3K185L activation, GABA responses at
the holding potential (−50 mV) were shunted (Figure 4a right
hand; Supplementary Figure 3B right hand), and IVGABA
reversed close to that holding potential (−52.5± 1.1mV, n=12,
P=0.0195 compared to control, Figure 4b right hand,
Figure 4 Intrinsic membrane properties of neurons with enduring GlyR α3K185L activation. (a) Primary hippocampal neurons were either transfected with mCherry alone or
with mCherry and GlyR α3K185L (185L) and cultured for 2–3 days under receptor-activating conditions (10 μM glycine). Neurons were investigated by perforated patch clamp
(gramicidin) and voltage clamped at − 50 mV. Under these conditions, the application of 100 μM GABA lead to hyperpolarizing currents in most of the control neurons (a, left).
GABA-evoked currents at the holding potential of − 50 mV in GlyR α3K185L-expressing neurons were strongly diminished (a, right). Current–voltage (IV) relationships were
obtained by applying voltage ramps from− 100 to− 30 mVevery 5 s. Note that current traces during the voltage ramps are not shown. The time points for determination of IVGABA
and IVbas are indicated. (b) The IVs of GABA-evoked currents were determined by subtracting the IVs in the presence and absence of GABA. Traces from individual cells are
shown. The yellow-boxed high-power view between the two IV plots shows magnified IV curves of the depicted areas from recordings of the control cell left hand (black trace) and
the GlyR α3K185L-positive cell right hand (red trace) in the presence of 10 μM glycine. (c–e) The perforated patch-clamp experiments revealed that RN, Vrev and EGABA were
decreased in neurons with continuous GlyR α3K185L activation. Note that washout of glycine from the extracellular solution only partially rescued RN, Vrev and EGABA. Numbers in
the bar graphs indicate the number of neurons analyzed. Statistical significance is indicated with *Po0.05, **Po0.01 and ***Po0.001
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Figure 4e). Consequently, the calculated driving force of
GABA responses was 4.9±2.9 mV in control neurons (n= 12;
Figure 5d), whereas it was close to 0 mV (−0.4± 0.9mV,
n= 12; Figure 5e) in neurons with enduring GlyR α3K185L
activation. Together with the strongly decreased RN
(Figure 4d), we conclude that enduring GlyR α3K185L
activation leads to large permanent Cl− conductance that
shunts GABA-dependent currents due to adaptation of
transmembraneCl− gradient according to imposedmembrane
potential.
We next asked whether acute glycine washout during
recording of neurons with activated GlyR α3K185L would have
effects on Vrev and EGABA (Figures 4c–e). However, Vrev and
EGABA remained at more depolarized potentials compared to
control neurons (−49.2±2.4 mV for Vrev, −50.8± 1.5mV
for EGABA, n=11), and RN recovered only partially
(Figure 4d; 107.8±30.5 MΩ, n= 12 in 10 μM glycine versus
203.9±47.2 MΩ, n=11 after glycine washout; P= 0.0006).
As GABAAR-dependent currents were observed upon glycine
washout (Supplementary Figure 3B, right hand) GABAAR
downregulation as a reason for observed effects regarding
EGABA can be ruled out. Thus, enduring GlyR α3K
185L
activation during 3 days induced long-lasting changes in
neuronal intrinsic membrane properties, which might involve
changes in permeability for different ions including, besides
Cl−, also K+, a well known major driving force of resting
membrane potential generation.
Enduring GlyR α3K185L activation persistently changes
resting membrane potential. We finally investigated resting
membrane potential (Vm) in current-clamp configuration
(Supplementary Figures 3C and D). We clamped current at
0 pA and determined apparent Vm of neurons with continuous
GlyR α3K185L activation in 10 μM glycine. Actually, Vm of GlyR
α3K185L-expressing neurons in 10 μM glycine required
2–3min to stabilize after switching from voltage- to current-
clamp configuration, and Vm slowly depolarized under these
conditions from values around − 50mV (i.e., the formerly
Figure 5 KCC2 does not rescue neuronal intrinsic membrane properties of neurons with enduring GlyR α3K185L activation. Primary hippocampal neurons were either co-
transfected with GlyR α3K185L and mCherry, KCC2wt-2A-mCherry or KCC2pr-2A-mCherry (Supplementary Figure 1B) and cultured for 2–3 days in the presence of 10 μM
glycine (Gly). Hatched bars correspond to conditions with KCC2 co-expression, and for the purpose of direct comparison red and faded red bars shown in Figures 4c–e are shown
here again. RN (a), Vrev (b) and EGABA (c) were determined with gramicidin-perforated patch-clamp experiments in the voltage-clamp mode. Note that co-expression of KCC2wt or
KCC2pr had no significant effect on any of the investigated parameters that reflect neuronal intrinsic membrane properties. (d and e) Calculated driving forces for GABAAR
responses. (d) Summary of the driving forces for GABAAR responses of cultured hippocampal neurons transfected with either mCherry, KCC2wt-2A-mCherry or KCC2pr-2A-
mCherry, calculated by subtraction of Vrev from EGABA values. See Supplementary Figure 1 for constructs and Supplementary Figure 4 for sample traces from KCC2-2A-
mCherry-expressing neurons. Compared to mCherry-transfected neurons, KCC2wt expression had no significant effect on the GABA driving forces of DIV 8–10 hippocampal
neurons. In contrast, overexpression of KCC2pr significantly shifted the driving forces for GABAAR responses toward more negative values. The change in the driving forces is
due to a negative shift of EGABA (Supplementary Figure 4), not of Vrev, indicating that the intracellular Cl
− concentration was changed by KCC2pr, not by KCC2wt, after 2–4 days of
overexpression. Note that the calculated GABAAR driving forces were not dependent on the extracellular glycine concentration (0 or 10 μM) during the perforated patch-clamp
experiments. (e) Same as d, except that GlyR α3K185L was co-expressed with mCherry, KCC2wt-2A-mCherry or KCC2pr-2A-mCherry. Owing to the large GlyR α3K185L-
dependent Cl− shunt all calculated driving forces were close to 0 mV. Numbers in the bar graphs indicate the number of neurons analyzed. Statistical significance is indicated with
*Po0.05, **Po0.01 and ***Po0.001
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imposed holding potential) to values determined in current-
clamp configuration reflecting apparent Vm (Supplementary
Figure 3C). These slow adaptations of membrane potential
consistently occurred only in 10 μM glycine and in GlyR
α3K185L-expressing neurons indicating that outwardly direc-
ted Cl− currents through GlyR α3K185L slowly decrease [Cl−]i
and thereby depolarize Vm. Hence, these experiments
revealed that Vm was significantly more depolarized in
neurons with activated GlyR α3K185L compared to control
neurons (Supplementary Figure 3D; −35.9±2.6 mV, n=5
versus − 51.2±2.4 mV, n=9; P=0.0104). As acute
glycine washout significantly influenced Vm (Supplementary
Figure 3D; −35.9± 2.6mV, n=5 in 10 μM glycine versus
−44.8± 2.2mV, n=10 upon glycine washout; P=0.0026),
while no differences were observed in control neurons
(Supplementary Figure 3D; − 52.6±2.4 mV, n=8 in 10 μM
glycine versus −51.2± 2.4mV, n=7 upon glycine washout;
P=0.6953), these data suggest that enduring GlyR α3K185L
activation shifts Vm toward ECl. After glycine washout, Vm
remained more depolarized in GlyR α3K185L-expressing
neurons compared to control neurons (P=0.0306), and
hence as discussed above, these results consolidate
conclusion that enduring GlyR α3K185L activation induced
long-lasting changes of neuronal intrinsic membrane proper-
ties. A priori, these results suggest that KCC2 expression
may prevent persistent changes in intrinsic membrane
properties and possibly involve Cl− transport in neuroprotec-
tion, as suggested earlier.14,15
KCC2 Cl− transport activity is not relevant for neuropro-
tection. Gramicidin-perforated patch clamp was used again
to analyze the effects of co-expression of KCC2wt on
membrane properties of neurons with enduring GlyR
α3K185L activation. KCC2-positive neurons were identified
according to 2A-self-cleaving peptide-coupled mCherry
(Supplementary Figure 1B). KCC2wt was not able to
substantially change neuronal intrinsic membrane properties
of GlyR α3K185L-expressing neurons (Figure 5). Similar to
mCherry/GlyR α3K185L-expressing neurons in 10 μM glycine
(Figure 4), RN remained significantly decreased
(77.6±12.8 MΩ, n= 9, Figure 5a), and Vrev and EGABA also
shifted toward imposed holding potential of − 50mV
when KCC2wt was co-expressed (−53.4±1.4 mV and
−53.7± 2.5mV, respectively, n=8, Figures 5b and c;
calculated driving forces for GABAAR responses,
Figure 5e). This suggests that KCC2wt Cl− transport activity
was not sufficient to overcome GlyR α3K185L-mediated Cl−
conductance. Moreover, upon acute glycine washout, Vrev
and EGABA remained largely unchanged (Figures 5b and c),
and RN recovered only partially (Figure 5a), similar to
neurons with enduring GlyR α3K185L activation in the
absence of KCC2wt (Figure 4d). Thus, co-expression of
KCC2wt was not able to prevent persistent changes in
intrinsic membrane properties of neurons with enduring GlyR
α3K185L activation. For control purpose, we checked KCC2
Cl− transport functionality and recorded KCC2wt-positive
neurons in the absence of GlyR α3K185L expression
(Supplementary Figure 4). Surprisingly, no significant differ-
ences in EGABA were found between control neurons (EGABA:
−58.7± 2.3mV, n=12) and those expressing KCC2wt
(EGABA: −55.4± 2.8mV, n=7, P=0.3920; Supplementary
Figure 4B and Figure 5d). However, a mutant variant of KCC2
(‘KCC2pr’; Supplementary Figure 1A), which should be
resistant to phosphorylation-dependent downregulation of
Cl− transport activity24,25 shifted EGABA in neurons without
GlyR α3K185L co-expression (KCC2pr: − 65.8±1.5 mV, n=8;
P= 0.0325 versus control: − 58.7±2.3 mV, n= 12; P= 0.0049
versus KCC2wt: −55.4± 2.8mV, n= 7; Supplementary
Figures 4A and B; Figure 5d). These results were confirmed
using recording of intracellular Ca2+ dynamics with Oregon
Green 488 (Life Technologies, Darmstadt, Germany) in
response to GABA application in more immature hippocam-
pal neurons at DIV 6–7 (Supplementary Figure 5). Again,
KCC2wt was not able to prevent GABA-induced increases in
intracellular Ca2+ signals in hippocampal neurons without
GlyR α3K185L co-expression (FGABA/FKCl: 0.21±0.04, n= 29
for KCC2wt versus 0.23± 0.02, n=114 for untransfected
neurons, P=0.7666; Supplementary Figure 5C), whereas
the KCC2pr mutant was effective (FGABA/FKCl: 0.12± 0.03,
n= 29 for KCC2pr versus 0.22±0.02, n=110 for untrans-
fected neurons, P=0.0107; Supplementary Figure 5C).
Importantly, KCC2wt and KCC2pr Cl− transport activities
were apparent in primary cortical neurons under these
conditions (FGABA/FKCl: 0.11±0.03, n=36 for KCC2wt
versus 0.40± 0.03, n=158 for untransfected neurons,
Po0.001; FGABA/FKCl: 0.08± 0.03, n= 44 for KCC2pr versus
0.50±0.03, n=188 for untransfected neurons, Po0.001;
Supplementary Figure 5D). Hence, KCC2wt is a functional
Cl− transporter, and cortical and hippocampal neurons reveal
phosphorylation-dependent differences in the regulation of
KCC2 Cl− transport activity. However, because KCC2wt
protected hippocampal neurons against GlyR α3K185L
activation-dependent neurodegeneration (Figure 1), these
results also suggest that Cl− extrusion is not relevant to
KCC2-dependent neuroprotection. Indeed, block of Cl−
import activity through NKCC1 using bumetanide (10 μM)
also failed to rescue neuronal survival (Figure 6a).
The KCC2-NTD mediates neuroprotection in the GlyR
α3K185L model of neurodegeneration. KCC2 was pre-
viously shown to have a protein structural role for synapto-
genesis by interaction with cytoskeleton-associated protein
4.1N.5,26 This finding encouraged us to clarify if cytoskeletal
signaling is involved in neuroprotection, but KCC2-C568A
mutant which is unable to interact with protein 4.1N and Cl−
transport-deficient5,26 rescued survival of neurons with
continuous GlyR α3K185L activation as well as KCC2wt
(Figure 6b; Supplementary Table 1). Furthermore, KCC2pr-
C568A rescued neuronal survival indicating that KCC2-
dependent neuroprotection is independent of phosphoryla-
tion of Y903, T906, T1007 and Y1087 in the KCC2-CTD
(Supplementary Figure 1A). These results reveal that KCC2-
dependent neuroprotection is independent of protein 4.1N-
dependent cytoskeletal signaling and further strengthen our
conclusion that KCC2-dependent neuroprotection does not
rely on Cl− transport. They also suggest that it is not the
KCC2-CTD, which mediates neuroprotection. Indeed, dele-
tion of NTD, not of CTD, abolished KCC2-dependent
neuroprotection (Figure 6b; Supplementary Table 1). Reci-
procally, co-expression of the KCC2-NTD, not of KCC2-CTD,
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rescued survival of neurons with enduring GlyR α3K185L
activation (Figure 6b). That KCC2-ΔNTD or KCC2-CTD failed
to protect neurons was not due to poor protein expression
(Supplementary Figure 6). These results identify KCC2-NTD
as relevant neuroprotective signaling domain.
KCC2-NTD mediates neuroprotection in the NMDA-
dependent model of excitotoxicity. To sustain the finding
that KCC2-NTD plays a pivotal role in neuroprotection, we
investigated whether neuroprotective function of KCC2-NTD
holds in another model of neurodegeneration. In contrast to
our GlyR α3K185L-dependent model of neurodegeneration,
which uses chronic silencing of neuronal activity, the NMDA-
dependent excitotoxicity model relies on neuronal over-
excitation. Actually, KCC2 Cl− transport activity was recently
postulated to mediate neuroprotection in the NMDA model of
neurodegeneration.15 Therefore, we tested KCC2wt and
mutant KCC2 variants coupled to EGFP via 2A peptides
(Supplementary Figure 1) in the NMDA-dependent model of
neurodegeneration.15 Neurons were transfected at DIV 6 with
non-edited GlyR α3K185P (to assess neuronal morphology in
addition to appearance of pyknotic nuclei for quantification of
neurodegeneration, Figures 7a and b), kept in culture for two
days (in non-GlyR-activating conditions), and then incubated
for 30min in 40 μM NMDA in the absence or presence
(10 μM) of glycine before maintaining the culture for 24 h as
described by Pellegrino et al.15 Glycine is a co-agonist of
NMDARs and therefore is expected to enhance the effect of
NMDA with regard to neurodegeneration, but NMDAR
internalization27 may interfere with this process. However,
NMDA effects on neuronal survival in the absence and
presence (10 μM) of glycine were comparable, though slightly
more pronounced in the presence of glycine (Figures 7c and d;
Supplementary Table 1). Co-expression of KCC2wt and
KCC2pr protected neurons against NMDA-induced excito-
toxicity (Figure 7c), and the Cl− transport-deficient KCC2wt/
pr-C568A mutants also succeeded (Figure 7c; Supplementary
Table 1). Most importantly, KCC2-ΔNTD and KCC2-CTD
failed to protect neurons against NMDA-induced excito-
toxicity, whereas KCC2-ΔCTD and KCC2-NTD rescued
neuronal survival (Figures 7c and d), similar to our GlyR
model of neurodegeneration. Thus, in contrast to previous
findings,15 our results identify a common mechanism of
KCC2-dependent neuroprotection in different models of
neurodegeneration, which is independent of Cl− transport
activity but involves the KCC2-NTD.
Discussion
We elucidated the mechanisms of KCC2-dependent neuro-
protection and identify a protein structural role of KCC2-NTD in
neuroprotection in the glycine-dependent model of chronic
neuronal silencing14 and the NMDA-dependent model of
excitotoxicity.15
Mechanisms of neurodegeneration. Our study ruled out
the possibility that inability of chronically silent neurons to
become spontaneously activated and participate in sponta-
neous neural activity in the developing network is a reason for
GlyR α3K185L-dependent neurodegeneration because block
of GABAAR activation, which provides a major driving force
for spontaneous neuronal activity at this developmental stage
in the culture dish (Supplementary Figure 2) or action
potential-dependent synaptic transmission did not influence
survival of neurons with enduring GlyR α3K185L activation.
Rather, all results synergistically point to enduring GlyR
α3K185L activation dependent, long-lasting changes of neu-
ronal intrinsic physiological properties involving decreased
RN, Vrev and Vm as reasons for GlyR α3K
185L-dependent
neurodegeneration. Actually, plasma membrane perforation
and resulting impairment of intracellular ion homeostasis
were recently associated with the pathophysiology of
Alzheimer's disease28 but GlyR α3K185L-dependent neuro-
degeneration could not be associated with increased
intracellular resting [Ca2+] as it may be the case in patients
with Alzheimer’s disease.28 This is possibly due to inactiva-
tion of, or changes in, expression of voltage-gated Ca2+
channels as a consequence of decreased Vm in neurons with
enduring GlyR α3K185L activation.
Figure 6 Protein structural role of KCC2 in neuroprotection. (a) The antagonist bumetanide (10 μM) of the Cl− transporter NKCC1 has no effect on neuronal survival
irrespectively of whether hippocampal neurons were challenged with tonic GlyR α3K185L activation or not. (b) The Cl− transport-deficient KCC2wt/pr-C568A as well as the
C-terminally truncated KCC2-ΔCTD were neuroprotective, whereas KCC2 constructs lacking the N-terminal domain (NTD) or containing only the isolated KCC2-CTD were not
neuroprotective. Note that the isolated KCC2-NTD was sufficient to mediate full rescue of neuronal survival. Numbers in the bar graphs indicate the number of cultures analyzed.
For values, see Supplementary Table 1. Statistical significance is indicated with ***Po0.001
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Figure 7 Protein structural aspects of KCC2-dependent neuroprotection in the NMDAmodel of neurodegeneration. (a and b) Images of control neurons (a) and neurons treated
for 30 min with 40 μM NMDA 24 h prior to fixation (b) are shown. GlyR α3K185P was expressed under non-receptor-activating conditions and surface stained in order to assess
neurodegeneration in the same way as in the GlyR-dependent model of neurodegeneration (Figure 1). Degenerated neurons could be identified by their fragmented dendrites and
pyknotic nuclei (b). (c) Quantification of the fraction of surviving neurons revealed that co-expression of KCC2wt or KCC2pr also protects NMDA-treated neurons. Again, Cl−
transport-deficient KCC2wt/pr-C568A also rescued neuronal survival. N-terminally truncated KCC2-ΔNTD or the isolated KCC2-CTD was not able to mediate neuroprotection.
Note that the isolated KCC2-NTD was sufficient to mediate full rescue of neuronal survival. (d) Quantification of the effects of glycine (10 μM) on NMDA-dependent excitotoxicity and
KCC2-dependent neuroprotection. Numbers in the bar graphs indicate the number of cultures analyzed. For values, see Supplementary Table 1. Statistical significance is indicated
with ***Po0.001
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In the hippocampus, RNA-edited GlyR α3K185L contributes
to tonic inhibition of cells with low GlyR β subunit protein
expression.14,29–34 RNA splicing generates the long variant
GlyR α3L185L, which is preponderantly expressed in the
hippocampus and operates at presynaptic sites by contributing
to regulation of neurotransmitter release.12,29,35,36 However, as
the ratio between α3K and α3L is increased in TLE patients with
hippocampal sclerosis (i.e., neurodegeneration),29 our results
regarding mechanisms of GlyR α3K185L-dependent neuro-
degeneration and KCC2-mediated neuroprotection are rele-
vant to the understanding of the pathophysiology of TLE.
RNA splicing and its regulatory impact on subcellular
distribution of ligand-gated GlyRs and GABAARs indeed
recently emerged as a critical determinant of neuronal
dysfunction in TLE,29,37–39 and non-synaptic Cl− channels
have also been implicated by other groups in neuronal
cell death. A recent study even provides a link between
non-synaptic NMDAR activation and excitotoxicity through
Ca2+-activated Cl− channel Clca1.18 With regard to neuro-
degeneration, alteration of non-synaptic Cl− channel function
thus represents an important determinant of cellular programs
that elicit cell death, and for this reason, care should be taken
when considering the use of glycine for neuroprotective
purposes.40–42
Identification of the neuroprotective capacity of the
KCC2-NTD in different models of neurodegeneration.
KCC2 is a developmentally regulated gene product, which
can undergo functional downregulation in the diseased
brain.7–9,43,44 Functional downregulation involves phosphor-
ylation of amino acids in the KCC2-CTD.24,25 In our study,
KCC2wt-dependent Cl− extrusion was apparent only in
cortical neurons (Supplementary Figure 5), which demon-
strates functionality of KCC2wt-dependent Cl− extrusion in
general, but also identifies neuron type-specific (cortical
versus hippocampal neurons) differences in the apparent
efficacy of Cl− extrusion through KCC2wt. The discrepancy to
other studies in which KCC2wt overexpression was reported
to significantly shift EGABA to hyperpolarized potentials in
cultured hippocampal neurons (e.g., Li et al.5 and Chudotvor-
ova et al.45) is probably due to differences in the cell culture
preparation (e.g., cell density, duration and strength of KCC2
expression, time point of investigation and percentage of
GABAergic interneurons in the culture dish). However,
hippocampal neurons in our culture preparations develop
normally as they are excitable and spontaneously active due
to depolarizing GABAAR signaling (Supplementary Figure 2).
Thus, the discrepancy to other studies might involve culture-
specific changes in the phosphorylation of the S940 site,
which was shown to enhance Cl− extrusion capacity of
KCC2wt.46,47 Nevertheless, as Cl− extrusion through the
KCC2pr variant (which cannot be phosphorylated at Y903,
T906, T1007 and Y1087) was apparent in our hippocampal
neuron preparations (Supplementary Figures 4 and 5, and
Figure 5d), our results clearly identify a role for these sites in
phosphorylation-dependent regulation of KCC2 Cl− extru-
sion, which is in agreement with mounting evidence for the
role of threonine phosphorylation in the downregulation of
KCC2-dependent Cl− transport (for review see Kahle et al.48).
Our results furthermore make a clarifying contribution to the
controversial discussion of the role of tyrosine phosphoryla-
tion in the regulation of KCC2 Cl− extrusion capacity48 as
they show that KCC2pr with unphosphorylatable threonine
and tyrosine residues has an increased Cl− extrusion
capacity. However, more detailed study is necessary to fully
clarify the role of threonine and tyrosine phosphorylation.
Beyond its ‘classical’ function as Cl− transporter that
contributes to the developmental switch of GABA action from
de- to hyperpolarization,3 KCC2 fulfills a protein structural
function, which contributes to co-regulation of glutamatergic
and GABAergic synapses during synaptogenesis in
development.4,5 The neuroprotective effect of KCC2 was
demonstrated already in 2008,14 but whether KCC2-
dependent neuroprotection involves a protein structural
function or regulation of intracellular [Cl−] is a matter of
debate.11,14,15 Although our initial study with GlyR-dependent
neuronal hypoactivity-induced neurodegeneration14 did not
address this question, a follow-up study showed that KCC2-
dependent neuroprotection depends on its Cl− transport
activity in the NMDA-dependent hyperexcitation model of
neurodegeneration.15
By challenging primary hippocampal neurons with these
two different experimental neurotoxic strategies including
enduring GlyR α3K185L activation associated with chronic
inhibition of neuronal activity as it may occur in the
hippocampus of TLE patients14 and NMDA-dependent
excitotoxicity,15 our study provides compelling evidence for a
protein structural role of KCC2 in neuroprotection. This
conclusion is based on the fact that both KCC2wt (which did
not effectively show Cl− extrusion in primary hippocampal
neurons; Supplementary Figures 4 and 5, and Figures 5d and e)
and Cl− transport-deficient KCC2-C568A rescued neuronal
survival in both neurotoxic conditions. Most strikingly, the
KCC2-NTD was neuroprotective in both experimental models
of neurodegeneration. All these results provide evidence for a
protein structural neuroprotective role of KCC2 in neuropro-
tection, and consistently, our study identifies the KCC2-NTD
as the relevant KCC2 protein domain sufficient for neuropro-
tection. In contrast to the rather large (299 amino acid
encompassing) KCC2-CTD with its well-established protein
structural role in synapse formation,4,5 ectopic expression of
the relatively compact, 100 amino acid spanning, KCC2-NTD
(Supplementary Figure 1A) is a novel suitable but non-
exclusive strategy to prevent neurodegeneration in TLE and
other neurodegenerative diseases as it would work indepen-
dently of the KCC2-CTD (involved in regulation of synapse
formation) or full-length KCC2-dependent regulation of chlor-
ide transport. Thus, KCC2 is a moonlighting protein49 as it is
not only a protein with Cl− transport activity but also harbors
several protein domains with synaptogenic and neuroprotec-
tive activities (Figure 8).
Materials and Methods
Molecular cloning. A cDNA coding for hKCC2b wildtype (designated ‘wt’)
was kindly provided by the laboratory of Kai Kaila (Helsinki, Finland) and recently
used in one of our studies.14 The KCC2a cDNA was cloned from human
postmortem hippocampus RNA (pool of 20 healthy Caucasians, Clontech
(Palo Alto, CA, USA). By using the 2A-self-processing peptide EGRGSLLTCGD-
VEENPGP derived from Thosea asigna,50 we generated constructs for expression
of KCC2 and mCherry or EGFP from polycistronic mRNA (Supplementary
Mechanisms of KCC2-dependent neuroprotection
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Figure 1). To generate the phosphorylation-resistant variant KCC2pr, which
cannot be functionally downregulated, we substituted by site-directed mutagen-
esis (GeneEditor, Promega, Mannheim, Germany) alanine and phenylalanine for
threonine and tyrosine, respectively, at the relevant positions in the CTD;24,25 see
Supplementary Figure 1 for sequence details. The amino acid substitution C568A
was generated using QuickChange Lightning site-directed mutagenesis kit
(Agilent Technologies, Waldbronn, Germany). Truncations were generated using
the full-length KCC2 constructs and appropriate primer sets. All the KCC2
constructs for neuronal expression are equipped with a cytomegalovirus (CMV)
enhancer-human synapsin-1 promoter (hSyn1). All the constructs contain the
woodchuck posttranscriptional regulatory element (WPRE), which was derived
from a lentiviral vector (Clontech). All expression constructs were verified with
DNA sequencing. Molecular cloning of GlyR α3K185P and GlyR α3K185L
constructs is described in former publications of our laboratory.10
Cell culture and transfection. All animals were killed according to the
permit given by the Office for Health Protection and Technical Safety of the regional
government of Berlin (LaGeSo, 0122/07) and in compliance with regulations laid
down in the European Community Council Directive. Hippocampal cells
were isolated from E19 Wistar rats and kept in B27-supplemented Neurobasal
medium (Life Technologies) in 24-well plates as described.14 Transfection was
carried out on DIV 6 using 300 ng DNA per well in combination with Effectene
transfection reagent (Qiagen, Hilden, Germany), following the manufacturer's
protocol as described.14 Either low (185P) or high (185L) affinity receptor types of
the short (K) splice variant of GlyR α310 were expressed for the duration of 3 days
in the presence or absence of added glycine (0, 10 or 400 μM). For this purpose, a
glycine-free minimal essential medium was used.14 In some experiments, neurons
were exposed to NMDA (40 μM) for 30 min in the absence or presence of 10 μM
glycine and analyzed 24 h after application. For co-transfection, 60 ng of KCC2-
coding plasmids were mixed with 240 ng GlyR α3K185L. For Oregon Green imaging
of GABA-elicited Ca2+ signals, neurons were investigated at an earlier time point in
cell culture, at DIV 6–7.
Chemicals. HEPES (4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid) and all
inorganic salts as well as glycine (G7126), GABA (A2129), NMDA (M3262),
gramicidin (G5002), lucifer yellow (L0144) and bicuculline methiodide (14343) were
purchased from Sigma-Aldrich (Steinheim, Germany). GABAzine (1262) came from
Tocris (Bristol, UK), TTX (6973.1) from Carl Roth (Karlsruhe, Germany), 4-bromo-
A-23187 (BML-CA101-0001) and ionomycin (LKT-I5753-M001) from ENZO Life
Sciences (Lörrach, Germany). Fura-2/AM and Oregon Green 488/AM were
purchased from Life Technologies. Stock solutions were made with H2O in the case
of TTX (1 mM), glycine and GABA (1 M each), and with DMSO (dimethyl sulfoxide)
(SERVA Electrophoresis GmbH, Heidelberg, Germany) in the case of gramicidin,
4-bromo-A-23187 and ionomycin (10 mM each).
Immunochemistry. A polyclonal chicken antibody was used to visualize HA-
tagged surface GlyR (1 : 200, Bethyl Laboratories, Montgomery, TX, USA). The
secondary antibody was made in donkey, conjugated with indocarbocyanine (Cy3)
and purchased from Jackson ImmunoResearch Laboratories (Suffolk, UK). Surface
staining of HA-tagged GlyR α3K was performed for 5 min at 37 °C in cell culture
medium, as described.14,29 Prior to fixation with paraformaldehyde (PFA) cells were
washed three times with cell culture medium. For fixation with PFA, cells were
incubated for 15 min at room temperature (RT) with ice-cold PBS containing 4%
PFA and 4% sucrose, followed by three wash steps in PBS. Incubation of fixed cells
in freshly made 50 mM NH4Cl for 15 min at RT was used to quench free aldehyde
groups from the PFA fixation. Cells were then again washed three times in PBS and
blocked with PBS/gelatine (0.1%) prior to permeabilization with 0.12% Triton X-100
(Sigma-Aldrich) in PBS/gelatine for 4 min at RT. Before incubation with first
antibodies, coverslips were again washed with PBS/gelatine. In some experiments,
KCC2 was stained for 1 h at RT using a rabbit polyclonal antibody (#07-432; Merck
Millipore, Germany) diluted 1 : 200 in PBS/gelatine. Prior to incubation with
secondary antibodies cells were washed three times with PBS/gelatine. For KCC2
stainings, a secondary antibody made in donkey and conjugated with
indocarbocyanine (Cy5, Jackson ImmunoResearch Laboratories) was used. After
45 min of incubation at RT cells were again washed three times with PBS/gelatine
followed by additional two wash steps in PBS. Stained cell preparations were
finally mounted on microscope slides using DAPI-containing vectashield medium
(Vector Laboratories, Peterborough, UK).
Electrophysiology. An EPC-7 amplifier and Patchmaster software (HEKA,
Lambrecht, Germany) were used for patch-clamp recordings. Patch pipettes, made
from borosilicate glass (Science Products, Hofheim, Germany), had resistances of
2–6 MΩ when filled with the intracellular solution containing (in mM) KCl (130),
NaCl (5), CaCl2 (0.5), MgCl2 (1), EGTA (5) and HEPES (30). Application of
substances was gravity driven. The tip (360 μM) of a perfusion pencil (AutoMate
Scientific, Berkeley, CA, USA) was placed close (ca 100 μM) to the recorded neuron
to ensure relatively rapid application of substances. Under these conditions, the
wash-in duration of lucifer yellow-containing test solution was o500 ms. For the
perforation of the patch, the pipette solution contained additionally 50–100 μM
gramicidin and 100 μM lucifer yellow, which allowed monitoring the stability of the
perforated patch (Supplementary Figure 3A). In addition, a strong shift of the
baseline current due to the high Cl− concentration in the pipette solution indicated
membrane rupture upon transition to whole-cell configuration. In this case, the
recording was stopped. The standard extracellular solution (E1; pH 7.4) contained
(in mM) NaCl (140), KCl (5), MgCl2 (1), CaCl2 (2), HEPES-NaOH (10) and glucose
(10). In the voltage-clamp mode, neurons were clamped at a potential of − 50 mV.
IV relationships were obtained from voltage ramps from − 100 to − 30 mV with a
duration of 140 ms applied every 5 s. Series and input resistances were checked
throughout the whole duration of each experiment by applying − 5 mV pulses prior
to the voltage ramps. All data were acquired with a sampling rate of 10 kHz after
filtering at 2.8 kHz. All experiments were performed at RT (20–25 °C).
Calcium imaging. Prior to ratiometric and non-ratiometric Ca2+ imaging
experiments cells were loaded with fura-2/AM or Oregon Green 488/AM,
respectively, by incubating the cells in E1 buffer (see above) supplemented with
1–5 μM of fura-2 or Oregon Green for 20 min at 37 °C. Subsequently, cells were
incubated for further 20 min in E1 to ensure deesterification. Glass coverslips with
the dye-loaded neurons were placed into a recording chamber (ca 1 ml volume) on
Figure 8 Different functional roles of KCC2. The scheme summarizes previous results and findings presented here. (a) Full-length KCC2 is a Cl− transporter that can be
positively (S940; green) or negatively (Y903, T906, T1007 and Y1087; red, this study) regulated by phosphorylation. (b) The synaptogenic function of the KCC2-CTD (blue) is
established and described elsewhere.5,26 (c) Neuroprotective function of the isolated KCC2 N-terminal domain (KCC2-NTD, this study)
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the stage of an Axiovert 10 or an Axio Lab.A1 micoroscope (both Zeiss,
Oberkochen, Germany). Cells were submerged with a constant flow of E1 through
an infusion pipette, which was placed in close vicinity (ca 200 μm) to the recorded
cells to ensure short wash-in/washout durations. Transfected cells were identified by
the fluorescence of mCherry, which served as control or was co-expressed using
the 2A-self-cleaving peptide in KCC2 constructs (see Supplementary Figure 1B for
constructs). Ratiometric measurements were performed with the Polychrome V, a
Clara Interline CCD camera (Andor Technology, Belfast, UK) and Live Acquisition
software (Till Photonics, Martinsried, Germany) using 340 and 380-nm excitation
wavelengths. Excitation and emission light were separated by a 510-nm dichroic
mirror. The emitted light was filtered using a 530-nm longpass filter. Exposure times
were 20 ms (340 nm) and 5 ms (380 nm), and the rate for [Ca2+] measurement was
set to one pair of images per 1 sec. 50 mM KCl were applied to check the viability of
the cells. To obtain minimal (0 mM) and maximal (10 mM) Ca2+ signals for
calibration,20 cells were permeabilized with either 10 μM ionomycin or 10 μM 4-
bromo-antibiotic A23187. 2 mM Mn2+ were applied at the end of each experiment to
quench the signal and thus to obtain background fluorescence that was subtracted




¼ KD ´ ðF380;min=F380;maxÞ ´ ððR RminÞ=ðRmax  RÞÞ;
where KD is the dissociation constant of the fura-2-Ca
2+complex (225 nM51).
F380,min and F380,max are the fluorescence values of free (0 mM, min) and Ca
2+-bound
(10 mM, max) fura-2. R, Rmin, Rmax are the fluorescence ratios (F340/F380) at the
beginning of the experiment (R) and after permeabilization in 0 mM (Rmin) and 10 mM
(Rmax) Ca
2+, respectively. Non-ratiometric experiments were performed with an
HBO-100 lamp (OSRAM GmbH, Munich, Germany), an electronic shutter, a SPOT
pursuit camera and Metamorph software (Visitron Systems, Puchheim, Germany).
Oregon Green fluorescence was excited and detected using an appropriate filter set
(XF22, Omega Opticals, Olching, Germany) using 100 ms shutter open times at a
frequency of three per second. Oregon Green fluorescence signals are expressed as
FGABA/FKCl, where FKCl and FGABA are the fluorescence values in the presence of E1
supplemented with 50 mM KCl (90 mM instead of 140 mM NaCl) and 100 μM GABA,
respectively.
Data analysis and statistics. All numerical data are reported as mean±S.E.M.
Statistical analysis (ANOVA and post hoc Tukey's test) was performed using the
software IGOR Pro 6.3 (WaveMetrics, Lake Oswego, OR, USA). Significance levels
are indicated as *Po0.05, **Po0.01 and ***Po0.001.
Quantitative data of neuronal survival is presented as values that are normalized to
the number of vital neurons in control conditions. Degenerated and vital neurons were
counted from at least three independent hippocampal cell cultures. The number of
experiments is indicated in brackets in the bar graphs. The conditions GlyR α3K185P
and α3K185L in the presence of 10 μM glycine were included in each experiment for
normalization purpose.
Vrev was calculated by determining the voltage at which no net current was observed
(zero point of the basal IV curve in the absence of GABA, IVbas). The values presented
in figures and text are not corrected for the liquid junction potential (+3.75 mV). EGABA
was obtained by determining the zero point of the GABA IV relationship that was
calculated by subtraction of IVbas from IVGABA (Figure 4). Analysis was performed by a
homemade procedure written using IGOR Pro 6.3 (WaveMetrics).
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 Suppl. Table 1 
Overview over the transfections, medium conditions, survival rates (% vital), number of 
experiments [N (HC)] and analyzed neurons [N (neurons)], and significant differences 
between control (α3K185P, normalized to 100%) and the different experimental conditions (P). 
P values are the results from posthoc Tukey test (after ANOVA1) of all values of the 
respective figure. Neurodegenerative conditions are colored red, and experimental 
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Suppl. Fig. 1: KCC2 protein structure. (A) Membrane topology of KCC2. The N- (red) and C-terminal 
(blue) domains, Exon1 (green), the location of C568 as well as the KCC2wt threonine and tyrosine 
phosphorylation sites (red dots) are illustrated. The position of the S940 phosphorylation site in the 
C-terminal KCC2 domain sequence that is involved in up-regulation of KCC2 Cl- extrusion capacity is 
indicated in green color. Protein sequences corresponding to the transmembrane domains 9-12 are 
shown underlined and light blue. (B) Scheme illustrating our KCC2 expression constructs. KCC2 was 
coupled either to EGFP or to mCherry via 2A self-processing peptides. Furthermore, constructs 
contained the woodchuck posttranscriptional regulatory element (WPRE) which was derived from a 
lentiviral vector (Clontech).  
 
Suppl. Fig. 2: Sponteanous postsynaptic currents (sPSCs) of DIV6-7 primary hippocampal neurons. 
(A) DIC image of a recorded hippocampal neuron. The bath application was placed close to (at ∼100 
µm distance to) the recorded neurons to reduce wash-in duration and artifacts. (B) An increase of the 
extracellular K+ concentration from 5 mM to 15 mM leads to a depolarizing shift of the basal 
membrane current (at -50 mV holding potential) and a strong increase in sPSC frequency. (C) 
Bicuculline (20 µM) and 10 µM DNQX as well as 50 µM APV were used to block GABAARs and 
AMPARs/NMDARs, respectively. Representative traces show the effects of bicuculline and 
DNQX/APV on sPSCs in the presence of 15 mM KCl. (D-F) Quantification of basal whole-cell currents 
(-50 mV, D), input resistances (E) and sPSC frequencies (F) in 5 mM and 15 mM extracellular KCl. Note 
that sPSCs at DIV6-7 are mediated by GABAARs and AMPARs/NMDARs, but bicuculline alone sufficed 
to largely prevent the 15 mM KCl-dependent increase in sPSC frequency (F). Numbers in the bar 
graphs indicate the number of neurons analyzed. Statistical significance is indicated with *: P < 0.05. 
 
Suppl. Fig. 3: Electrophysiological properties of GlyR α3K185L-expressing neurons. (A) The images 
illustrate the perforated patch clamp procedure. Transfected neurons were identified by their 
mCherry fluorescence (right top). Pipette solution contained 50-100 µM gramicidin and 100 µM 
lucifer yellow to monitor the stability of the perforated patch (left bottom). When the patch was 
disrupted, Lucifer yellow diffused into the soma (right bottom) and the recording configuration 
switched to the whole-cell mode. In this case, the recording was stopped. (B) Primary hippocampal 
neurons were either transfected with mCherry alone (Control) or with mCherry and GlyR α3K185L 
(185L) and cultured for 2-3 days under receptor-activating conditions (10 µM glycine). Neurons were 
investigated by perforated patch clamp (Gramicidin) and voltage-clamped at different holding 
potentials (-80 mV to -50 mV). In control neurons at 10 µM glycine, the application of 100 µM GABA 
lead to strong hyper- and de-polarizing currents depending on the holding potential (B, left). In 
contrast, GABA-evoked currents in GlyR α3K185L-expressing neurons were strongly diminished at all 
potentials tested (B, right, red), indicating the large shunt elicited by GlyR α3K185L activation. Indeed, 
in nominally glycine-free recording solution (wash-out), GABA-evoked currents also appeared in GlyR 
α3K185L-expressing neurons (B, right, light red). (C) Vm of GlyR α3K185L-expressing neurons at 10 µM 
glycine was determined 1-3 min after the switch from the voltage (VC) to the current-clamp (CC) 
configuration, since membrane potentials slowly depolarized under these conditions from values 
around -50 mV (the former holding potential) to final values of -35.9 ± 2.6 mV (n = 5) when the 
voltage clamp at -50 mV was withdrawn (C, red curve). In contrast, Vm of control cells (black curve) 
was significantly more negative and relatively constant. What could be the reason for different 
values of Vm (current clamp) and Vrev (voltage clamp; e.g. Figure 4)? Neuronal membranes are not 
passive and may therefore reveal presence of a couple of voltage-activated conductances which are 
fixed by the holding potential in the voltage clamp mode but can “equilibrate” when current-
clamped at 0 pA. Indeed, the Vrev (and EGABA) of GlyR α3K185L-expressing neurons was clamped 
towards the imposed holding potential (-50 mV) in the voltage clamp configuration due to the large 
Cl- conductance. When the voltage clamp was released, resting membrane potential (Vm) was 
established according to all the different conductances in the neuronal plasma membrane. The slow 
depolarization of Vm in GlyR α3K185L-expressing neurons after switching into current clamp indicates 
on the one hand the large GlyR α3K185L conductance of those neurons and can therefore, on the 
other hand, be considered as the equilibration of intracellular Cl- through GlyR α3K185L channels; 
please note here that intracellular Cl- is NOT fixed by the pipette solution in all these experiments as 
they were gramicidin-perforated measurements. (D) Summary of the resting membrane potentials 
(Vm) obtained in perforated patch clamp experiments in the current clamp configuration (at 0 pA). 
Numbers in the bar graphs indicate the number of neurons analyzed. Statistical significance is 
indicated with *: P < 0.05, **: P < 0.01. 
 
Suppl. Fig. 4: Cl- transport activity of KCC2wt and KCC2pr in hippocampal neurons. (A) Primary 
hippocampal neurons were either transfected with mCherry (Control), KCC2wt-2A-mCherry or 
KCC2pr-2A-mCherry and investigated by perforated patch clamp (gramicidin) in the voltage-clamp 
configuration (holding potential: -50 mV). The application of 100 µM GABA lead to hyperpolarizing 
currents in most of the control and KCC2-expressing neurons (top, time points for determination of 
IVbasal and IVGABA are indicated in current traces). Current-voltage relationships (IV) were obtained by 
applying every 5 s voltage ramps ranging from -100 mV to -30 mV. The IVs of GABA-evoked currents 
(EGABA) were determined by subtracting the IVs in the presence and absence of GABA. (B) 
Quantification of EGABA revealed that only KCC2pr, not KCC2wt, was able to shift neuronal EGABA 
significantly to more hyperpolarized values. Numbers in the bar graphs indicate the number of 
neurons analyzed. Statistical significance is indicated with *: P < 0.05, **: P < 0.01. 
 
Suppl. Fig. 5: Non-ratiometric Ca2+ imaging with Oregon green (OG488) in primary neurons. (A) 
Oregon green (OG488) fluorescence was used to quantify the effects of KCC2 expression on GABA-
elicited Ca2+ signals. (A, top) Schematic representation of the constructs illustrates that mCherry, 
KCC2wt-2A-mCherry or KCC2pr-2A-mCherry are flanked by the human synapsin-1 promoter (hSyn1) 
and the Woodchuck posttranscriptional regulatory element (WPRE). The red dots indicate positions 
of the threonine and tyrosine residues that were mutated in the KCC2pr construct. (A, bottom) 
Representative images of a view field centered on a transfected cortical neuron are shown. 
Transfected neurons were identified according to mCherry fluorescence (boxed in red color) and 
analyzed at DIV6-7 simultaneously with neighboring untransfected cells (boxed in grey color). Oregon 
green signals in response to GABA (100 µM) or KCl (50 mM) application are shown. Representative 
traces (B) show alterations in F/F0 in response to application of GABA or KCl in untransfected cells 
(grey) and in a KCC2wt-positive cortical neuron (red). GABA application led to Ca2+ elevations in 
untransfected cells but not in the KCC2wt-expressing neurons, indicating a KCC2-dependent shift in 
EGABA. (C and D) Quantification of GABA-dependent Ca2+ signals normalized to KCl-dependent Ca2+ 
signals (FGABA/FKCl) measured in hippocampal (C) or cortical neurons (D). Black and hatched bars 
identify transfected neurons, while grey bars identify neighboring non-transfected neurons. Note 
that only KCC2pr decreased GABA-mediated Ca2+ elevations in both hippocampal and cortical 
neurons, whereas KCC2wt was effective only in cortical neurons, which confirms its Cl- transport 
activity and reveals neuron type-specific and phosphorylation-dependent differences in the 
regulation of Cl- transport through KCC2. Numbers in the bar graphs indicate the number of neurons 
analyzed. Statistical significance is indicated with **: P < 0.01, ***: P < 0.001. 
 
Suppl. Fig. 6: Qualitative immunochemical analysis of the protein expression of KCC2 variants. 
Images of neurons co-transfected with GlyR α3K185P and KCC2wt-2A-EGFP, KCC2wt-∆NTD-2A-EGFP, 
and KCC2wt-CTD-2A-EGFP are shown. HA-epitope tagged and surface-stained GlyR α3K185P (red), 
DAPI (blue) and EGFP (green) are shown in top panels. KCC2 was stained using a rabbit polyclonal 
antibody which binds to the C-terminus of KCC2. Bottom panels show corresponding 































SUPPL. FIGURE 6 
